Temefos

Temefos

SCHEMBL10455340

COP(=S)(OC)Oc1ccc(Sc2ccc(OP(=S)(OC)OC)cc2)cc1.ClCCl

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
ALDH1A1 P00352 3/20 0.47
CYP3A4 P08684 3/20 0.47
HSD17B10 Q99714 3/20 0.47
MAPK1 P28482 2/20 0.47
THRB P10828 2/20 0.47
TP53 P04637 1/20 0.47
TSHR P16473 2/20 0.45
PTGIR P43119 4/20 0.37
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
STS P08842 4/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Temefos SCHEMBL44105 0.93 LMNA (0.53) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
Temefos SCHEMBL23303378 0.93 LMNA (0.53) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
Temefos SCHEMBL8741692 0.91 LMNA (0.51) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
Temefos SCHEMBL6388031 0.91 LMNA (0.51) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
Temefos SCHEMBL15553439 0.89 LMNA (0.51) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
Temefos SCHEMBL9809762 0.89 LMNA (0.42) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
Temefos SCHEMBL20919592 0.82 ALDH1A1 (0.46) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
SCHEMBL30412917 0.81 CYP3A4 (0.53) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
Temefos SCHEMBL9193178 0.80 LMNA (0.54) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
Temefos SCHEMBL9435846 0.80 LMNA (0.40) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0381296-A1 Kit for use in the treatment of osteoporosis THE PROCTER & GAMBLE COMPANY (US) 1990-08-08 EP claimed